Warning letter
DO&CO Aktiengesellschaft/DO&CO, Inc.: warning letter of Mar 30, 2026
FDA warning letter 717773 · Human Foods Program
Key facts
| Reference number | 717773 |
|---|---|
| Company | DO&CO Aktiengesellschaft/DO&CO, Inc. |
| Subject | CGMP/Food/Prepared, Packed or Held Under Insanitary Conditions/Adulterated/L. monocytogenes |
| Issue date | Mar 30, 2026 |
| Posted date | May 5, 2026 |
| Issuing office | Human Foods Program |
| Product type | Food/Cosmetics |
| CFR sections cited | 117, 117.35(a), 117.150(a)(1)(ii), 117.135(a)(1), 117.135(c)(3), 117.165(b)(3), 117.150(a)(2) |
| Inspection city | Romulus |
| Inspection ZIP | 48174 |
| Inspection start date | Jul 23, 2025 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: